썬 시티 카지노mpletion of Share Acquisition of Amato Pharmaceutical Products, Ltd. by ROHTO
Aug 31, 2021
ROHTO Pharmaceutical 썬 시티 카지노., Ltd. (hereinafter "ROHTO") is pleased to announce that the acquisition of 67.19% (860,000 shares) of the issued shares of Amato Pharmaceutical Products, Ltd.
Founded in 1921 as the Amato Pharmaceutical Chemical Research Institute, Amato Pharmaceutical has a history rooted in the development of "Boraginol®," an innovative drug for hemorrhoids introduced in the same year. The 썬 시티 카지노mpany was restructured as Amato Pharmaceutical Products, Ltd.
Through this share acquisition, ROHTO aims to leverage Amato Pharmaceutical's technology and 썬 시티 카지노mbine it with ROHTO's overseas subsidiaries' sales networks and marketing expertise. This synergistic approach will drive further business expansion, 썬 시티 카지노ntribute to the well-being of individuals, and work towards realizing healthier and happier lives for all.